Tradestie Institutional Equity Comparison Engine

PROK vs EVMN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EVMN Overall Edge

EVMN Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Evommune, Inc. (EVMN) driven by superior Growth & Margin, Options & Structure while PROK counters with relative strength in Momentum & Technical. Fundamentally, PROK trades at N/M Forward P/E with -24871.4% operating margin (-19.8% YoY revenue) versus EVMN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PROK sits in BREAKDOWN (51st %ile IV; Dealer Gamma Walls on Pro) against EVMN sits in SURGE (53rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PROK N/M vs EVMN N/M Fwd P/E
Growth & Margin Winner EVMN
Op Margin -24871.4% vs 0.0% ยท YoY -19.8% vs +0.0%
Momentum & Technical Winner PROK
1Y -54.4% vs -61.0% ยท 52W Pos 10% vs 8%
Options & Structure Winner EVMN
BREAKDOWN (51st %ile IV) vs SURGE (53rd %ile IV)
PROK NASDAQ
ProKidney Corp. Class A Ordinary Shares
Biological Products, (No Disgnostic Substances)
$1.04
-0.48% 1D
Market Cap $417.2M
1M Return -21.8%
1Y Return -54.39%
Forward P/E N/M
Unified AI Score
54.0 / 100 HOLD
Tech 33.0 Fund 65.0 Flow 68.0 Mom 60.0
EVMN US Equity
Evommune, Inc.
Pharmaceutical Preparations
$7.10
-6.95% 1D
Market Cap $315.5M
1M Return +37.33%
1Y Return -61.03%
Forward P/E N/M
Unified AI Score
30.0 / 100 SELL
Tech 50.0 Fund 35.0 Flow 69.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PROK -54.39% EVMN -61.03% Spread: +6.64 pp (PROK Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PROK Revenue EVMN Revenue PROK Op. Margin EVMN Op. Margin Margin Edge
FY2024 $0M $10M -241678.9% -1000.2% EVMN
FY2025 $0M $10M -18477.8% -623.6% EVMN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PROK (4) vs EVMN (3)
Institutional Metric PROK EVMN Criterion Row Winner
Market Capitalization Scale $417.2M $315.5M Larger Scale PROK
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -19.8% +0.0% Higher Growth EVMN
Operating Margin (TTM) Profitability -24871.4% 0.0% Higher Margin EVMN
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -73.4% -69.5% Higher ROE EVMN
52-Week Range Position Momentum 10% ($1โ€“$3) 8% ($5โ€“$33) Stronger Trend PROK
Beta / 30D Volatility Risk Regime 1.68ฮฒ ยท 92% Vol 1.05ฮฒ ยท 118% Vol Lower Realized Risk PROK
Unified Institutional Score Composite Signal 54.0 / 100 (HOLD) 30.0 / 100 (SELL) Higher Composite PROK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PROK vs EVMN Buy Guide
PROK BREAKDOWN
50d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 51st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live PROK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EVMN SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EVMN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PROK nor EVMN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.